Bronchospasm and Obstruction
1
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Nebulizer
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 1 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Research Network
Common Treatments
- Nebulizer1
Active Sponsors
- Ligue Pulmonaire Neuchâteloise1
- University Hospital St Luc, Brussels1
- Haute Ecole de Santé Vaud1
- Université Catholique de Louvain1
Top Investigators
Université Catholique de Louvain, Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Pneumologie, ORL & Dermatologie, 1200 Brussels, Belgium
Ligue Pulmonaire Neuchâteloise
Cliniques Universitaires Saint-Luc (service de pneumologie), Université Catholique de Louvain
Cliniques Universitaires Saint-Luc (service des soins intensifs)
Cliniques Universitaires Saint-Luc (service de pneumologie), Haute Ecole de Santé Vaud (filière physiothérapie), Université Catholique de Louvain
Related Conditions
- Acute Respiratory Insufficiency1
- Chronic Respiratory Insufficiency1